| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.11B | 57.40B | 25.07B | 15.88B | 65.10B | 64.88B |
| Gross Profit | 16.11B | 18.75B | 25.07B | 15.88B | 17.41B | 20.52B |
| EBITDA | 0.00 | 7.03B | 7.08B | 0.00 | 8.14B | 0.00 |
| Net Income | 5.39B | 5.36B | 5.26B | 5.08B | 6.11B | 8.63B |
Balance Sheet | ||||||
| Total Assets | 1.82T | 1.94T | 1.84T | 1.73T | 1.66T | 1.58T |
| Cash, Cash Equivalents and Short-Term Investments | 100.87B | 215.70B | 171.63B | 142.12B | 142.71B | 152.41B |
| Total Debt | 325.83B | 670.86B | 294.76B | 272.04B | 280.91B | 246.65B |
| Total Liabilities | 1.71T | 1.83T | 1.73T | 1.62T | 1.55T | 1.48T |
| Stockholders Equity | 113.32B | 104.27B | 110.12B | 114.40B | 109.95B | 106.56B |
Cash Flow | ||||||
| Free Cash Flow | -25.27B | 16.24B | -30.61B | 80.71B | 25.96B | 82.42B |
| Operating Cash Flow | -24.80B | 16.66B | -30.05B | 81.31B | 26.83B | 82.99B |
| Investing Cash Flow | -67.50B | -74.28B | -43.31B | -59.11B | -65.25B | -76.07B |
| Financing Cash Flow | 90.04B | 81.30B | 128.07B | 30.93B | 23.41B | 5.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$16.15B | 7.00 | 5.34% | 3.57% | 6.65% | 16.74% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | HK$14.39B | 1.90 | 4.62% | 6.13% | -3.34% | -22.01% | |
59 Neutral | HK$14.59B | 3.84 | 5.60% | 5.32% | -1.24% | 4.34% | |
58 Neutral | HK$12.24B | 1.68 | 3.11% | 4.24% | -7.58% | 12.65% | |
57 Neutral | HK$15.28B | 2.83 | 4.11% | ― | -5.76% | 18.15% | |
54 Neutral | HK$16.29B | 4.21 | 3.63% | 1.89% | -5.02% | -3.28% |